|
|
The Competitive Intelligence Report Microsomal Triglyceride Transfer Protein (MTP) Inhibitors as of September 2008 provides a competitor analysis in the development pipeline of novel MTP inhibitors for treatment of hypercholesterolemia and obesity.The report includes a compilation of current active projects in research and development of novel MTP inhibitors. Competitor projects are listed in a tabular format providing Information on:
|
Additional Information
Competitor Analysis Series delivers
Related Markets
Drug Discovery Reports
- Retinal Vein Occlusion Therapeutics - Pipeline Assessment and Market Forecasts to 2019
- Patient Perspectives - Patient Reported Outcomes Drive Drug Development, but Improving Patient Involvement Remains a Challenge
- Arthritis Therapeutics Market to 2018 - Novel Oral JAK Inhibitors and Biologic Disease Modifying Anti-Rheumatic Drugs (DMARD) Will Drive Continued Growth Across Key Indications
- Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 5th Edition
- Non-Alcoholic Steatohepatitis Global Clinical Trials Review, H1, 2012

